The approval of the expanded age range was based on data from a clinical trial which evaluated the efficacy of Gardasil (quadrivalent human papillomavirus recombinant vaccine) in 3253 women 27-45 ...

Hundreds of studies, including gold-standard clinical trials, challenge Health Secretary Robert F. Kennedy Jr.’s claim that ...

Make no mistake about it: We're living in a time where there seems to be not much good news in sight, and women's health care—specifically with regard to cancer rates increasing among young women—is ...

The Food and Drug Administration (FDA) approved an expanded age indication for GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), according to Merck, the manufacturer of the HPV vaccine.

WASHINGTON (AP) — A single HPV vaccination appears just as effective as two doses at preventing the viral infection that ...